Rinvoq ER (Upadacitinib)

Rinvoq ER (Upadacitinib) is a prescription medication used for the treatment of rheumatoid arthritis (RA) in adults. It is a type of medication known as a JAK inhibitor, which works by blocking specific enzymes involved in the body's immune response. Rinvoq ER is an extended-release form of upadacitinib, which means that it is taken once daily and releases the medication slowly into the body over time.

Directions

Take Rinvoq ER exactly as prescribed by your doctor. It is typically taken once daily with or without food. Do not change the dosage or stop taking the medication without first talking to your doctor. It is important to continue taking Rinvoq ER even if you feel well, as it may take several weeks or months to see the full effects of the medication.

Ingredients

The active ingredient in Rinvoq ER is upadacitinib. The medication is available in 15mg and 30mg tablets.

Cautions

Rinvoq ER may increase the risk of serious infections, including tuberculosis. It is important to tell your doctor if you have any history of infections or if you have been in close contact with someone who has tuberculosis. Rinvoq ER may also increase the risk of blood clots, so be sure to tell your doctor if you have a history of blood clots or if you are taking any blood thinners. Additionally, Rinvoq ER may cause harm to a developing fetus, so it is important to use effective birth control while taking this medication.

Side Effects

The most common side effects of Rinvoq ER include upper respiratory tract infections, headache, and high blood pressure. Other potential side effects include decreased white blood cell count, increased cholesterol levels, and liver enzyme abnormalities. If you experience any side effects, it is important to contact your doctor. In rare cases, Rinvoq ER may cause serious side effects such as heart attack, stroke, or blood clots, so it is important to seek immediate medical attention if you experience any unusual symptoms.